Association of fatty liver disease with nonfatal cardiovascular events in patients undergoing maintenance hemodialysis. (Q54312430)

27 May 2018

title

Association of fatty liver disease with nonfatal cardiovascular events in patients undergoing maintenance hemodialysis. (English)

1 reference

27 May 2018

1 reference

Yu-Cheng Lai

1

1 reference

27 May 2018

Ben-Chung Cheng

2

1 reference

27 May 2018

Jyh-Chang Hwang

3

1 reference

27 May 2018

Yueh-Ting Lee

4

1 reference

27 May 2018

Chien-Hua Chiu

5

1 reference

27 May 2018

Li-Chueh Kuo

6

1 reference

27 May 2018

Jin-Bor Chen

7

1 reference

27 May 2018

publication date

1 January 2013

1 reference

27 May 2018

published in

The Nephron Journals

1 reference

27 May 2018

volume

124

1 reference

27 May 2018

issue

3-4

1 reference

27 May 2018

page(s)

218-223

1 reference

27 May 2018

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

cites work

1 reference

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

21 January 2018

1 reference

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

21 January 2018

1 reference

Inflammation and cardiovascular risk in dialysis patients.

21 January 2018

1 reference

Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study

21 January 2018

1 reference

Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001

21 January 2018

1 reference

Should we quantify insulin resistance in patients with renal disease?

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

21 January 2018

1 reference

Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?

21 January 2018

1 reference

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

21 January 2018

1 reference

Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals

21 January 2018

1 reference

Carotid artery intima-media thickness in nonalcoholic fatty liver disease

21 January 2018

1 reference

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

21 January 2018

1 reference

Non-alcoholic steatohepatitis: from cell biology to clinical practice

21 January 2018

1 reference

Causes and metabolic consequences of Fatty liver

21 January 2018

1 reference

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000357952

1 reference

27 May 2018

PubMed ID

24503573

1 reference

27 May 2018